1. Mardaneh, P., Pirhadi, S., Mohabbati, M., Khoshneviszadeh, M., Rezaei, Z., Saso, L., Edraki, N., Firuzi, O. Design, synthesis and pharmacological evaluation of 1,4-naphthoquinone- 1,2,3-triazole hybrids as new anticancer agents with multi-kinase inhibitory activity. Journal of Molecular Structure. Dec 25

2. Alipour, A., Farhadi, P., Mobaraki, K., Mardaneh, P., Mohammadi, S., Khoshneviszadeh, M., Pirhadi, S., Poustforoosh, A., Saso, L., Edraki, N., Firuzi, O. Spiroisatin pyranopyrimide derivatives as receptor tyrosine kinase inhibitors and targeted anticancer agents. Jun 25

3. Shayan, Z., Khoddami, N., Jafari, P., Askarian, M., Borazjani, R. Gender Differences in Nurses' Knowledge, Practice, and Attitudes Towards Contact Isolation Precautions: A Measurement Invariance Study. Mar 31

 4. Eskandari, M., Moosavi, F., Nazari, S., Mardaneh, P., Poustforoosh, A., Zargari, F., Mohabbati, M., Saso, L., Edraki, N., Firuzi, O. N-ethyl morpholine-deca hydroacridine 1, 8-diones as novel P-gp inhibitors and multidrug resistance reversal agents in cancer cells. Mar 15

5. Emami, L., Hoshyar, S., Bina, S., Zare, F., Mardaneh, P., Haghshenas, M., Poustforoosh, A., Firouzabadi, N., Rashedinia, M. Binding interaction of food preservatives with glycosylated DNA: In vitro assessment and computational studies. Mar 5

6. Valipour, M., Zakeri khatir, Z., Ayati, A., Hosseini, A., Sheibani, M., Irannejad, H. Advances in the selective c-MET kinase inhibitors: Application of fused [5,6]-Bicyclic nitrogen-containing cores for anticancer drug design. Feb 15

7. Alborz, M., Mohammadizadeh, M., Mardaneh, P., Hassani, B., Mohabbati, M., Firuzi, O. New and efficient one-pot method for the synthesis of spiro[indoline-2,1′-isobenzofuran] derivatives and evaluation of their anticancer activity by in vitro and in silico studies. Feb 5

8. Akkus, M., Kirici, M., Poustforoosh, A., Erdogan, M., Gundogdu, R., Tüzün, B., Taslimi, P. Phenolic Compounds: Investigating Their Anti-Carbonic Anhydrase, Anti-Cholinesterase, Anticancer, Anticholinergic, and Antiepileptic Properties Through Molecular Docking, MM-GBSA, and Dynamics Analyses.

9. Poustforoosh, A. Optimizing kinase and PARP inhibitor combinations through machine learning and in silico approaches for targeted brain cancer therapy.

10. Naimi, N., Karimian, S., Dastyafteh, N., Noori, M., Mohammadi-Khanaposhtani, M., Dadgar, A., Larijani, B., Lotfi, V., Çelik, İ., Aktaş, A., Sadeghian, N., Taslimi, P. Naimi, N., Karimian, S., Dastyafteh, N., Noori, M., Mohammadi-Khanaposhtani, M., Dadgar, A., Larijani, B., Lotfi, V., Çelik, İ., Aktaş, A., Sadeghian, N., Taslimi, P.Jun 25

11. Nazari, S., Poustforoosh, A., Paul, P., Kukreti, R., Tavakkoli, M., Saso, L., Firuzi, O., Moosavi, F. c-MET tyrosine kinase inhibitors reverse drug resistance mediated by the ATP-binding cassette transporter B1 (ABCB1) in cancer cells. Jan 25

12. Mohammadizadeh, Sh., Karimian, S., Dastyafteh, N., Noori, M., Doraghi, F., Mohammadi-Khanaposhtani, M., Larijani, B; Mahdavi, M., Sadeghian, N., Aktaş, A., Taslimi, P., Gulçin, İ. Design of novel benzimidazole-propane hydrazide derivatives as α-glucosidase and α-amylase inhibitors: in vitro and in silico studies. Jan 25

13. Mahboubifar, M., Karami-Osboo, R., Jassbi, A. Essential Oils and Their Eco-friendly Encapsulated Products for Mycotoxins Reduction: Current Situation and Future Prospects. 28 February

14. Ataollahi, E., Emami, L., Mohammad Al-Dies, A., Zare, f., Poustforoosh, A., Emami, M., Saadat, F., Motamen, F., Rezaei, Z., Khabnadideh, S. Novel spiroisatin-pyranopyrazole hybrids as anticancer agents with TrkC inhibitory potential. 

15. Ghanbarlou, M., Karimian, S., Doraghi, F., Dadgar, A., S¸enol, I., Larijani, B., Mohammadi-Khanaposhtani, M., Aktas, A., Sadeghian, N., Taslimi, P., Ebrahimi-Rad, M., Mahdavi, M., Gülçin, I. 4-Phenylthiazol-1,2,3-triazole derivatives as new potential α-glucosidase and α-amylase inhibitors. 

16. Koohi-Hosseinabadi, O., Koohpeyma, F., Safarpour, A.R., Nematollahy, P., Kazemi, M., Shahriarirad, R., Tanideh, R., Mojahedtaghi, M., Ghaemmaghami, P., Iraji, A., Goudarzi, K., Tanideh, N. Antioxidant and anti-inflammatory effects of Equisetum arvense L. on acid-induced ulcerative colitis in rats. Dec 25

17. Taherkhani, A.M., Sayahi, M.H., Hassani, B., Dastyafteh, N., Mohammadi-Khanaposhtani, M., Rafiei, E., Meshkani, M., Safapoor, S., Tehrani, M., Larijani, B., Mahdavi, M., Firuzi, O., New benzothiazole-indole-1,2,3-triazole-N-phenylacetamide derivatives as cytotoxic agents: Design, synthesis, and in vitro cytotoxic evaluations. Aug 5

18. Valipour, M., Sheibani, M., Dibaei, M., Khatir, Z., Ayati, A., Motafeghi, F., Irannejad, H., Anticancer and Anti-Inflammatory Potential of Coptisine as a Planar Quaternary Benzo[C]Phenanthridine Alkaloid With G-Quadruplex DNA Telomeric Induction Activity. May 25

19. Emami, L., Moezi, L., Mardaneh, P., Sadeghian, S., Ataollahi, E., Divar, M., Zarei, S., Agah, S., Sabet, R., Khabnadideh, S., New spirooxindole-thiazolidine derivatives as antiseizure agents: Biological evaluation and computational studies. May 25

20. Moosavi, F., Firoozi, R., Tavakkoli, M., Nazari, S., Alipour, A., Firuzi, O., Combination of chemotherapy and c-MET inhibitors has synergistic effects in c-MET overexpressing pancreatic cancer cells. Apr 25

21. Moosavi, F., Divar, M., Khabnadideh, S., Tavakkoli, M., Mohabbati, M., Saso, L., Poustforoosh, A., Firuzi, O., Spiroindoline quinazolinedione derivatives as inhibitors of P-glycoprotein: potential agents for overcoming multidrug resistance in cancer therapy. 2025

22. Mohammadi, S., Mortazavia, M., Poustforoosh, A., Moosavi, F., Saso, L., Edraki, N., Firuzi, O., Novel spiroisatin-pyranopyrazole hybrids as anticancer agents with TrkC inhibitory potential.